219 related articles for article (PubMed ID: 8027925)
41. Interactions of beta- and hydroxypropyl-beta-cyclodextrin with some purine alkaloids: thermodynamic study.
Terekhova IV
Curr Drug Discov Technol; 2008 Jun; 5(2):168-72. PubMed ID: 18673256
[TBL] [Abstract][Full Text] [Related]
42. Effect of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs.
Müller BW; Albers E
J Pharm Sci; 1991 Jun; 80(6):599-604. PubMed ID: 1834826
[TBL] [Abstract][Full Text] [Related]
43. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
Hegge AB; Másson M; Kristensen S; Tønnesen HH
Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
[TBL] [Abstract][Full Text] [Related]
44. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
[TBL] [Abstract][Full Text] [Related]
45. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins.
Liu B; Li W; Nguyen TA; Zhao J
Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse.
Bentley MV; Vianna RF; Wilson S; Collett JH
J Pharm Pharmacol; 1997 Apr; 49(4):397-402. PubMed ID: 9232537
[TBL] [Abstract][Full Text] [Related]
47. Inclusion complexation of the sunscreen agent 2-ethylhexyl-p-dimethylaminobenzoate with hydroxypropyl-beta-cyclodextrin: effect on photostability.
Scalia S; Villani S; Casolari A
J Pharm Pharmacol; 1999 Dec; 51(12):1367-74. PubMed ID: 10678490
[TBL] [Abstract][Full Text] [Related]
48. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
[TBL] [Abstract][Full Text] [Related]
49. Solubilization of Fluasterone in cosolvent/cyclodextrin combinations.
He Y; Li P; Yalkowsky SH
Int J Pharm; 2003 Oct; 264(1-2):25-34. PubMed ID: 12972333
[TBL] [Abstract][Full Text] [Related]
50. Availability and activity of preservatives in emulsified systems.
Kurup TR; Wan LS; Chan LW
Pharm Acta Helv; 1991; 66(3):76-82. PubMed ID: 1763091
[TBL] [Abstract][Full Text] [Related]
51. Hydroxypropyl cyclodextrins: potential synergism with carcinogens.
Horský J; Pitha J
J Pharm Sci; 1996 Jan; 85(1):96-100. PubMed ID: 8926593
[TBL] [Abstract][Full Text] [Related]
52. Experimental and molecular docking investigations on the inclusion mechanism of the complex of phloridzin and hydroxypropyl-β-cyclodextrin.
Zhang CL; Liu JC; Yang WB; Chen DL; Jiao ZG
Food Chem; 2017 Jan; 215():124-8. PubMed ID: 27542458
[TBL] [Abstract][Full Text] [Related]
53. Antimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance.
Athanassiou G; Michaleas S; Lada-Chitiroglou E; Tsitsa T; Antoniadou-Vyza E
J Pharm Pharmacol; 2003 Mar; 55(3):291-300. PubMed ID: 12724033
[TBL] [Abstract][Full Text] [Related]
54. Inclusional complex study between 6-p-toluidinylnaphthalene-2-sulfonate and 2-hydroxypropyl-beta-cyclodextrin.
Dotsikas Y; Loukas YL
J Biochem Biophys Methods; 2002 Jul; 52(2):121-34. PubMed ID: 12204416
[TBL] [Abstract][Full Text] [Related]
55. Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state.
Hirayama F; Wang Z; Uekama K
Pharm Res; 1994 Dec; 11(12):1766-70. PubMed ID: 7899242
[TBL] [Abstract][Full Text] [Related]
56. 2-Hydroxypropyl-beta-cyclodextrin extracts 2-phenylphenol from silicone tubing.
den Brok MW; van der Schoot SC; Nuijen B; Hillebrand MJ; Beijnen JH
Int J Pharm; 2004 Jul; 278(2):303-9. PubMed ID: 15196635
[TBL] [Abstract][Full Text] [Related]
57. Development of an omeprazole parenteral formulation with hydroxypropyl-beta-cyclodextrin.
Holvoet C; Heyden YV; Plaizier-Vercammen J
Pharm Dev Technol; 2007; 12(3):327-36. PubMed ID: 17613896
[TBL] [Abstract][Full Text] [Related]
58. Correlation of the solubility of several aromatics and terpenes in aqueous hydroxypropyl-beta-cyclodextrin with steric and hydrophobicity parameters.
Demian BA
Carbohydr Res; 2000 Oct; 328(4):635-9. PubMed ID: 11093722
[TBL] [Abstract][Full Text] [Related]
59. Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl.
McCandless R; Yalkowsky SH
J Pharm Sci; 1998 Dec; 87(12):1639-42. PubMed ID: 10189280
[TBL] [Abstract][Full Text] [Related]
60. Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins.
De Gaetano F; Cristiano MC; Paolino D; Celesti C; Iannazzo D; Pistarà V; Iraci N; Ventura CA
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
